Literature DB >> 10954278

Can induction of systemic hypotension help prevent nidus rupture complicating arteriovenous malformation embolization?: analysis of underlying mechanism achieved using a theoretical model.

T F Massoud1, G J Hademenos, W L Young, E Gao, J Pile-Spellman.   

Abstract

BACKGROUND AND
PURPOSE: Nidus rupture is a serious complication of intracranial arteriovenous malformation (AVM) embolotherapy, but its pathogenetic mechanisms are not well described. An AVM model based on electrical network analysis was used to investigate theoretically the potential role of hemodynamic perturbations for elevating the risk of nidus vessel rupture (Rrupt) after simulated AVM embolotherapy, and to assess the potential benefit of systemic hypotension for preventing rupture.
METHODS: Five separate hypothetical mechanisms for nidus hemorrhage were studied: 1) intranidal rerouting of blood pressure; 2) extranidal rerouting of blood pressure; 3) occlusion of draining veins with glue; 4) delayed thrombosis of draining veins; and 5) excessively high injection pressures proximal to the nidus. Simulated occlusion of vessels or elevated injection pressures were implemented into the AVM model, and electrical circuit analysis revealed the consequent changes in intranidal flow, pressure, and Rrupt for the nidus vessels. An expression for Rrupt was derived based on the functional distribution of the critical radii of component vessels. If AVM rupture was observed (Rrupt > or = 100%) at systemic normotension (mean pressure [P] = 74 mm Hg), the theoretical embolization was repeated under systemic hypotension (minor P = 70 mm Hg, moderate P = 50 mm Hg, or profound P = 25 mm Hg) to assess the potential benefit of this maneuver in reducing hemorrhage rates.
RESULTS: All five pathogenetic mechanisms under investigation were able to produce rupture of AVMs during or after embolotherapy. These different mechanisms had in common the capability of generating surges in intranidal hemodynamic parameters resulting in nidus vessel rupture. The theoretical induction of systemic hypotension during and after treatment was shown to be of significant benefit in attenuating these surges and reducing Rrupt to safer levels below 100%.
CONCLUSION: The induction of systemic hypotension during and after AVM embolization would appear theoretically to be of potential use in preventing iatrogenic nidus hemorrhage. The described AVM model should serve as a useful research tool for further theoretical investigations of AVM embolotherapy and its hemodynamic sequelae.

Entities:  

Mesh:

Year:  2000        PMID: 10954278      PMCID: PMC8174900     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  50 in total

1.  Artificial embolization of cerebral arteries. Report of use in a case of arteriovenous malformation.

Authors:  A J LUESSENHOP; W T SPENCE
Journal:  J Am Med Assoc       Date:  1960-03-12

2.  Cerebral arteriovenous malformation feeding artery aneurysms: a theoretical model of intravascular pressure changes after treatment.

Authors:  E Gao; W L Young; J Pile-Spellman; S Joshi; H Duong; P E Stieg; Q Ma
Journal:  Neurosurgery       Date:  1997-12       Impact factor: 4.654

3.  A biomathematical model of intracranial arteriovenous malformations based on electrical network analysis: theory and hemodynamics.

Authors:  G J Hademenos; T F Massoud; F Viñuela
Journal:  Neurosurgery       Date:  1996-05       Impact factor: 4.654

4.  Rupture of a cerebral aneurysm during embolization for a cerebral arteriovenous malformation.

Authors:  T Abe; S Nemoto; T Iwata; M Shimazu; K Matsumoto; K Liu
Journal:  AJNR Am J Neuroradiol       Date:  1995-10       Impact factor: 3.825

5.  Embolization of cerebral arteriovenous malformations: Part I--Technique, morphology, and complications.

Authors:  G Wikholm; C Lundqvist; P Svendsen
Journal:  Neurosurgery       Date:  1996-09       Impact factor: 4.654

6.  Normal perfusion pressure breakthrough theory.

Authors:  R F Spetzler; C B Wilson; P Weinstein; M Mehdorn; J Townsend; D Telles
Journal:  Clin Neurosurg       Date:  1978

7.  Preembolization superselective angiography: role in the treatment of brain arteriovenous malformations with isobutyl-2 cyanoacrylate.

Authors:  F Viñuela; A J Fox; G Debrun; D Pelz
Journal:  AJNR Am J Neuroradiol       Date:  1984 Nov-Dec       Impact factor: 3.825

8.  Evaluation of pressure changes in feeding arteries during embolization of intracerebral arteriovenous malformations.

Authors:  T Handa; M Negoro; S Miyachi; K Sugita
Journal:  J Neurosurg       Date:  1993-09       Impact factor: 5.115

9.  Progressive thrombosis of brain arteriovenous malformations after embolization with isobutyl 2-cyanoacrylate.

Authors:  F Viñuela; A J Fox; G Debrun; C G Drake; S J Peerless; J P Girvin
Journal:  AJNR Am J Neuroradiol       Date:  1983 Nov-Dec       Impact factor: 3.825

10.  Blood pressure monitoring in feeding arteries of cerebral arteriovenous malformations during embolization: a preventive role in hemodynamic complications.

Authors:  T Sorimachi; S Takeuchi; T Koike; T Minakawa; H Abe; R Tanaka
Journal:  Neurosurgery       Date:  1995-12       Impact factor: 4.654

View more
  8 in total

1.  Endovascular Treatment of Cerebral AVM: Our Experience with Onyx.

Authors:  A Pérez-Higueras; R Rossi López; D Quiñones Tapia
Journal:  Interv Neuroradiol       Date:  2005-10-27       Impact factor: 1.610

2.  Angioarchitectural characteristics associated with complications of embolization in supratentorial brain arteriovenous malformation.

Authors:  J Pan; H He; L Feng; F Viñuela; Z Wu; R Zhan
Journal:  AJNR Am J Neuroradiol       Date:  2013-07-25       Impact factor: 3.825

3.  Predictors of hemorrhagic complications from endovascular treatment of cerebral arteriovenous malformations.

Authors:  José A Jordan; Juan Carlos Llibre; Frank Vázquez; Raúl Rodríguez; José A Prince; José Carlos Ugarte
Journal:  Interv Neuroradiol       Date:  2014-02-10       Impact factor: 1.610

4.  Adjuvant embolization with N-butyl cyanoacrylate in the treatment of cerebral arteriovenous malformations: outcomes, complications, and predictors of neurologic deficits.

Authors:  Robert M Starke; Ricardo J Komotar; Marc L Otten; David K Hahn; Laura E Fischer; Brian Y Hwang; Matthew C Garrett; Robert R Sciacca; Michael B Sisti; Robert A Solomon; Sean D Lavine; E Sander Connolly; Philip M Meyers
Journal:  Stroke       Date:  2009-05-28       Impact factor: 7.914

5.  Clinical course and medical management of neonates with severe cardiac failure related to vein of Galen malformation.

Authors:  G P Frawley; P A Dargaville; P J Mitchell; B M Tress; P Loughnan
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2002-09       Impact factor: 5.747

6.  Simulation study of Hemodynamic in Bifurcations for Cerebral Arteriovenous Malformation using Electrical Analogy.

Authors:  Y Kiran Kumar; S B Mehta; M Ramachandra
Journal:  J Biomed Phys Eng       Date:  2017-06-01

7.  Endovascular transvenous treatment for superficial intracranial arteriovenous malformations.

Authors:  WeiXing Bai; YanYan He; YingKun He; Bin Xu; TianXiao Li; YuMing Xu
Journal:  J Interv Med       Date:  2019-09-14

8.  Successful anesthetic management for microsurgical excision of ruptured cerebellar arteriovenous malformation with trapped endovascular microcatheter.

Authors:  Shruti Redhu; B Madhusudhana Rao; Vinay Byrappa; K R Madhusudan Reddy
Journal:  J Anaesthesiol Clin Pharmacol       Date:  2014-07
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.